Stockscreener 앱 받기
26.66
11.08%
2.66
시간 외 거래:
26.36
-0.30
-1.13%
전일 마감가:
$24.00
열려 있는:
$24.4
하루 거래량:
47,457
Relative Volume:
4.36
시가총액:
$242.57M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+8.82%
1개월 성능:
+142.36%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$24.25
$27.55
1주일 범위
$20.27
$27.55
52주 변동 폭
$10.24
$27.55
Research Alliance Corp Iii Stock (RACC) Company Profile
명칭
Research Alliance Corp Iii
전화
(617) 778-2500
주소
600 FIFTH AVENUE, 23RD FLOOR, NEW YORK
Compare RACC vs LION, XXI, UMAC, CCXI, EVAC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RACC
Research Alliance Corp Iii
|
26.66 | 120.78M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
11.87 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.50 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
25.97 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
16.37 | 764.20M | 0 | 0 | 0 | 0.0647 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.25 | 597.92M | 0 | 12.80M | -714.00K | 0.2184 |
Research Alliance Corp Iii 주식(RACC)의 최신 뉴스
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - Fierce Biotech
OHB Pediatrics to go public through Research Alliance Corporation III pact - TipRanks
Oak Hill Bio goes public with ~$175M in proceeds - The Pharma Letter
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
Sierra Bancorp Q2 FY26 net income falls 7% to $9.9 million; revenue dips 1% to $39 million - Bitget
Iberdrola secures EUR 29 million EIB green loan for Labraza wind farm development - Bitget
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
EDGAR Filing Documents for 0001193125-26-316960 - SEC.gov
EDGAR Filing Documents for 0001193125-26-316954 - SEC.gov
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswire
RACC|Research Alliance III Ord Shs Class A|Price:11.000|Chg%:-0.250 - TradingKey
Research Alliance Corporation IV Revenue Breakdown – NASDAQ:RACD - TradingView
Enterprise value to revenue forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology - The American Journal of Managed Care® (AJMC®)
Meridia RE IV Socimi announces EUR 0.01 per share dividend for 2025 results - Bitget
COMMODORE CAPITAL LP Acquires 500,000 Shares in Research Alliance Corp IV - GuruFocus
Wesfarmers Price Target Raised 2% to A$88.00/Share by Macquarie - Bitget
RACD: Research Alliance Corporation IVFull Company Report - Zacks Investment Research
Henry William Stusnick Net Worth (2026) - GuruFocus
Research Alliance Holdings Iii Llc /cayman Net Worth (2026) - GuruFocus
Francis Sherman Adams Net Worth (2026) - GuruFocus
Research Alliance Corporation III (RACC) Stock Price, News & Analysis - MarketBeat
Research Alliance Holdings IV LLC Discloses Investment in Research Alliance Corporation IV with 17% Stake - TradingView
Research Alliance Corporation IV (RACD) sponsor reports 17% ownership - Stock Titan
Research Alliance Corp IV (RACD) investor group reports 5.5% ownership of Class A shares - Stock Titan
Biotechnology Value Fund (RACD) group reveals 6.4% Research Alliance stake - Stock Titan
Research Alliance Corporation IV Completes Initial Public Offering - TipRanks
Research Alliance IV prices IPO for $75M, deposits $75M trust; sponsor buys $2.75M private placement - TradingView
Commodore Capital takes 5.5% position in Research Alliance Corp IV (RACD) - Stock Titan
RACD Stock Latest News - TipRanks
Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD) - Stock Titan
Frontier tech research, news & data - MLQ.ai
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) stock historical prices and data - Yahoo Finance Australia
Cash flow from operating activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) Stock Chart and Price History 2026 - MarketBeat
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - MEXC
Cash flow from investing activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
Research Alliance Corp IV SEC Filing (Jul 13, 2026) - Stock Titan
Research Alliance Corp Iii (RACC) 재무 분석
Research Alliance Corp Iii (RACC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.23%
0.00%
자본화:
|
볼륨(24시간):